4.2
Chronische obstructieve longziekte II: Pathologie
De pathofysiologie van Chronische Obstructieve Longziekte (COPD) is ingewikkeld en veelzijdig, en omvat een complex samenspel van fysiologische proces…
Chronic obstructive pulmonary disease, or COPD , is primarily caused by chronic airway inflammation due to exposure to irritants such as cigarette smoke, dust, or air pollution.
Inflammatory cells, including lymphocytes, macrophages, and neutrophils, invade the airway wall, releasing harmful mediators like leukotrienes and cytokines.
Inhaled particles and oxidants produced by these inflammatory cells aggravate the inflammation.
Oxidants inhibit antiproteases compounds that protect against the breakdown of lung tissue.
Simultaneously, they increase the activity of proteases enzymes that degrade lung tissue.
This imbalance disrupts the natural balance between proteases and antiproteases, leading to the deterioration of alveoli and loss of lung elasticity.
As a result, the airways narrow, obstructing airflow, which promotes excessive mucus production and causes fluid buildup in the lungs.
In COPD, chronic inflammation causes oxidative stress, releasing free radicals that damage lung tissue, leading to bullae formation and alveolar wall deterioration, impairing gas exchange.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic airway inflammation in COPD?
COPD develops from chronic exposure to irritants like cigarette smoke, dust, and air pollution. These irritants trigger inflammatory cells—lymphocytes, macrophages, and neutrophils—to infiltrate airway walls and release harmful mediators such as leukotrienes and cytokines. This perpetuates ongoing inflammation and progressive lung damage characteristic of the disease.
Q2: How does the protease-antiprotease imbalance damage lung tissue in COPD?
Oxidants from cigarette smoke impair antiproteases like alpha-1 antitrypsin that normally protect lung tissue. Simultaneously, oxidants increase protease activity, particularly elastase, which degrades extracellular matrix components. This imbalance causes destruction of alveolar walls and lung parenchyma, leading to emphysema and loss of lung elasticity.
Q3: What role do free radicals play in COPD pathophysiology?
Chronic inflammation generates reactive oxygen species (ROS) like superoxide anions and hydroxyl radicals from cigarette smoke and inflammatory cells. These free radicals damage cellular structures, proteins, lipids, and DNA, further promoting inflammation and lung tissue deterioration. This oxidative stress perpetuates the cycle of tissue destruction in COPD.
Q4: How does airway narrowing occur in COPD?
Chronic inflammation causes structural changes and constriction in airways, reducing airflow. Mucus hypersecretion and mucosal edema exacerbate narrowing, while smooth muscle constriction further impedes airflow. Additionally, increased vascular permeability from inflammation leads to fluid accumulation in lungs, contributing to obstruction and airway blockage.
Q5: What structural changes occur in the lungs during COPD?
Ongoing tissue destruction causes alveolar enlargement and bullae formation—large air pockets within lung tissue. Destruction of alveolar walls reduces surface area for gas exchange, impairing oxygen uptake and carbon dioxide elimination. These structural changes decrease lung compliance and elasticity, leading to reduced oxygen uptake and shortness of breath.
Q6: How do inflammatory mediators perpetuate lung damage in COPD?
Inflammatory cells release cytokines, leukotrienes, and other mediators that perpetuate the inflammatory response. These mediators recruit additional inflammatory cells and sustain the release of proteases and oxidants. This creates a self-perpetuating cycle of inflammation and tissue destruction that characterizes COPD progression.
Q7: Why is gas exchange impaired in COPD?
Destruction of alveolar walls reduces the surface area available for oxygen and carbon dioxide exchange. Combined with fluid accumulation and airway obstruction, these structural changes impair gas exchange efficiency. Understanding these mechanisms is essential for developing effective chronic obstructive pulmonary disease management strategies.